The National Harm Reduction Technical Assistance Center (NHRTAC) Training Deck on Harm Reduction and Syringe Access is a customizable PowerPoint slide deck training designed to provide an overview on the foundations of harm reduction philosophy and practice, drug user health issues and trends, and increase cultural competence and humility when working with people who use drugs.
Unequal, unprepared, under threat: why bold action against inequalities is needed to end AIDS, stop COVID-19 and prepare for future pandemics.
The handout describes the main characteristics of LTBI and Active TB, as well as their differences. The material also describes what increases the risk for developing Active TB and how to prevent TB from developing. English is on one side and Dari is on the other.
The handout describes the main characteristics of LTBI and Active TB, as well as their differences. The material also describes what increases the risk for developing Active TB and how to prevent TB from developing. English is on one side and Pashto is on the other.
The Cultural Quick Reference Guide for Afghanistan provides country-specific information on cultural norms, health practices, treatment considerations, facts and traditional ideas about TB, and courtesies to observe to enhance communication.
CDC’s Division of STD Prevention, Using Technology to Advance STI Prevention (UTASP) Group, and the National Coalition of STD Directors are partnering to host the National Internet Partner Services (NIPS) Workgroup quarterly calls for technology-based partner services.
Are you having oral and/or anal sex? If so, you might need to get an STI test in your throat or butt. It’s quick and easy. This new fact sheet describes who should get tested, why get tested, what to expect, and tips for talking with your provider.
Recent news about HIV biomedical prevention research has been a mixed bag: very encouraging results from long-acting pre-exposure prophylaxis (PrEP) trials, but a disappointing lack of significant protection achieved with experimental HIV vaccines. Furthermore, the entire research effort has had to wrestle with the impact of the COVID-19 pandemic.
Presented on September 21, 2021 by the TB Centers of Excellence and the Centers for Disease Control and Prevention
On Thursday, June 11, HepVu convened a webinar to discuss the impact of COVID-19 on harm reduction services, issues encountered on the ground, and potential solutions.
